Neutrophil ablation with anti-serum does not protect against phase 2 ventricular arrhythmias in anaesthetised rats with myocardial infarction

Cardiovascular Research

Volumn 73, Issue 4, 2007, Pages 761-769

  Clements Jewery, Hugh ^b   Hearse, David J ^a   Curtis, Michael J ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Antiarrhythmic agents; Ischaemia; Myocardial infarction; Neutrophil; Nitric oxide; Reperfusion; Ventricular arrhythmias

Indexed keywords

ANTISERUM; MYELOPEROXIDASE; PENTOBARBITAL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY LIGATION; CORONARY ARTERY OBSTRUCTION; ENZYME ACTIVITY; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE EXTRASYSTOLE; HEART VENTRICLE FIBRILLATION; INCIDENCE; LEFT CORONARY ARTERY; MALE; NEUTROPENIA; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; RAT; TACHYCARDIA;

ANESTHESIA; ANIMALS; ELECTROCARDIOGRAPHY; IMMUNE SERA; MALE; MODELS, ANIMAL; MYOCARDIAL INFARCTION; MYOCARDIUM; NEUTROPHILS; PEROXIDASE; RABBITS; RATS; RATS, SPRAGUE-DAWLEY; VENTRICULAR FIBRILLATION; VENTRICULAR PREMATURE COMPLEXES;

EID: 33846893008     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cardiores.2006.12.017     Document Type: Article

References (51)

1. Billman G.E. A comprehensive review and analysis of 25 years of data from an in vivo canine model of sudden cardiac death: implications for future anti-arrhythmic drug development. Pharmacol Ther 111 (2006) 808-835
2. Sanguinetti M.C., and Bennett P.B. Antiarrhythmic drug target choices and screening. Circ Res 93 (2003) 491-499
3. Clements-Jewery H., Hearse D.J., and Curtis M.J. Phase 2 ventricular arrhythmias in acute myocardial infarction: a neglected target for therapeutic antiarrhythmic drug development and for safety pharmacology evaluation. Br J Pharmacol 145 (2005) 551-564
4. Harris A.S. Delayed development of ventricular ectopic rhythms following experimental coronary occlusion. Circulation 1 (1950) 1318-1328
5. Curtis M.J. Characterisation, utilisation and clinical relevance of isolated perfused heart models of ischaemia-induced ventricular fibrillation. Cardiovasc Res 39 (1998) 194-215
6. Meesmann W. Early arrhythmias and primary ventricular fibrillation after acute myocardial ischaemia in relation to pre-existing coronary collaterals. In: Parrat J.R. (Ed). Early Arrhythmias Resulting from Myocardial Ischaemia (1982), McMillan, London, UK 93-112
7. Clark C., Foreman M.I., Kane K.A., Mcdonald F.M., and Parratt J.R. Coronary artery ligation in anesthetized rats as a method for the production of experimental dysrhythmias and for the determination of infarct size. J Pharmacol Methods 3 (1980) 357-368
8. Johnston K.M., Macleod B.A., and Walker M.J. Responses to ligation of a coronary artery in conscious rats and the actions of antiarrhythmics. Can J Physiol Pharm 61 11 (1983) 1340-1353
9. Clements-Jewery H., Hearse D.J., and Curtis M.J. Independent contribution of catecholamines to arrhythmogenesis during evolving infarction in the isolated rat heart. Br J Pharmacol 135 (2002) 807-815
10. Ravingerova T., Tribulova N., Slezak J., and Curtis M.J. Brief, intermediate and prolonged ischemia in the isolated crystalloid perfused rat heart: relationship between susceptibility to arrhythmias and degree of ultrastructural injury. J Mol Cell Cardiol 279 (1995) 1937-1951
11. Clements-Jewery H., Hearse D.J., and Curtis M.J. The isolated blood-perfused rat heart: an inappropriate model for the study of ischaemia- and infarction-related ventricular fibrillation. Br J Pharmacol 137 (2002) 1089-1099
12. Sasaki K., Ueno A., Katori M., and Kikawada R. Detection of leukotriene B4 in cardiac tissue and its role in infarct extension through leucocyte migration. Cardiovasc Res 22 (1988) 142-148
13. Mullane K.M., Read N., Salmon J.A., and Moncada S. Role of leukocytes in acute myocardial infarction in anesthetized dogs: relationship to myocardial salvage by anti-inflammatory drugs. J Pharmacol Exp Ther 228 (1984) 510-522
14. Bennett G., Al-Rashed S., Hoult J.R., and Brain S.D. Nerve growth factor induced hyperalgesia in the rat hind paw is dependent on circulating neutrophils. Pain 77 (1998) 315-322
15. Curtis M.J., Macleod B.A., and Walker M.J. Models for the study of arrhythmias in myocardial ischaemia and infarction: the use of the rat. J Mol Cell Cardiol 19 (1987) 399-419
16. Milmer K.E., and Clough D.P. Optimum ventilation levels for maintenance of normal arterial blood pO2, pCO2, and pH in the pithed rat preparation. J Pharmacol Methods 10 (1983) 185-192
17. Walker M.J., Curtis M.J., Hearse D.J., Campbell R.W., Janse M.J., Yellon D.M., et al. The Lambeth Conventions: guidelines for the study of arrhythmias in ischaemia infarction, and reperfusion. Cardiovasc Res 22 (1988) 447-455
18. Ridley P.D., Yacoub M.H., and Curtis M.J. A modified model of global ischaemia: application to the study of syncytial mechanisms of arrhythmogenesis. Cardiovasc Res 26 (1992) 309-315
19. Pitchford S.C., Yano H., Lever R., Riffo-Vasquez Y., Ciferri S., Rose M.J., et al. Platelets are essential for leukocyte recruitment in allergic inflammation. J Allergy Clin Immunol 1121 (2003) 109-118
20. Mullane K.M., Kraemer R., and Smith B. Myeloperoxidase activity as a quantitative assessment of neutrophil infiltration into ischemic myocardium. J Pharmacol Methods 14 (1985) 157-167
21. Smith P.K., Krohn R.I., Hermanson G.T., Mallia A.K., Gartner F.H., Provenzano M.D., et al. Measurement of protein using bicinchoninic acid. Anal Biochem 150 (1985) 76-85
22. Curtis M.J., and Hearse D.J. Reperfusion-induced arrhythmias are critically dependent upon occluded zone size: relevance to the mechanism of arrhythmogenesis. J Mol Cell Cardiol 21 (1989) 625-637
23. Mainland D., Herrera L., and Sutcliffe M.I. Statistical Tables for Use with Binomial Samples - Contingency Tests, Confidence Limits and Sample Size Estimates (1956), University College of Medicine Publications, New York 52
24. Curtis M.J., Macleod B.A., and Walker M.J. Antiarrhythmic actions of verapamil against ischaemic arrhythmias in the rat. Br J Pharmacol 83 (1984) 373-385
25. Opitz C.F., Mitchell G.F., Pfeffer M.A., and Pfeffer J.M. Arrhythmias and death after coronary artery occlusion in the rat. Continuous telemetric ECG monitoring in conscious, untethered rats. Circulation 92 (1995) 253-261
26. Curtis M.J., and Hearse D.J. Ischaemia-induced and reperfusion-induced arrhythmias differ in their sensitivity to potassium: implications for mechanisms of initiation and maintenance of ventricular fibrillation. J Mol Cell Cardiol 21 (1989) 21-40
27. Frangogiannis N.G., Smith C.W., and Entman M.L. The inflammatory response in myocardial infarction. Cardiovasc Res 53 (2002) 31-47
28. Jordan J.E., Zhao Z.Q., and Vinten-Johansen J. The role of neutrophils in myocardial ischemia-reperfusion injury. Cardiovasc Res 43 (1999) 860-878
29. Engler R.L., Dahlgren M.D., Peterson M.A., Dobbs A., and Schmid-Schonbein G.W. Accumulation of polymorphonuclear leukocytes during 3-h experimental myocardial ischemia. Am J Physiol 251 (1986) H93-H100
30. Almeida A.P., Bayer B.M., Horakova Z., and Beaven M.A. Influence of indomethacin and other anti-inflammatory drugs on mobilization and production of neutrophils: studies with carrageenan-induced inflammation in rats. J Pharmacol Exp Ther 214 (1980) 74-79
31. Roberts R., Demello V., and Sobel B.E. Deleterious effects of methylprednisolone in patients with myocardial infarction. Circulation 53 (1976) [PG-I204-6]
32. Kloner R.A., Fishbein M.C., Lew H., Maroko P.R., and Braunwald E. Mummification of the infarcted myocardium by high dose corticosteroids. Circulation 57 (1978) 56-63
33. Coker S.J., Ledingham I.M., Parratt J.R., and Zeitlin I.J. Aspirin inhibits the early myocardial release of thromboxane B2 and ventricular ectopic activity following acute coronary artery occlusion in dogs. Br J Pharmacol 72 (1981) 593-595
34. Coker S.J., and Parratt J.R. The effects of prostaglandins E2, F2 alpha, prostacyclin, flurbiprofen and aspirin on arrhythmias resulting from coronary artery ligation in anaesthetized rats. Br J Pharmacol 74 (1981) 155-159
35. Johnston K.M., Macleod B.A., and Walker M.J. Effects of aspirin and prostacyclin on arrhythmias resulting from coronary artery ligation and on infarct size. Br J Pharmacol 78 (1983) 29-37
36. Rampart M., and Williams T.J. Suppression of inflammatory oedema by ibuprofen involving a mechanism independent of cyclo-oxygenase inhibition. Biochem Pharmacol 35 (1986) 581-586
37. Lepran I., Koltai M., and Szekeres L. Effect of non-steroid anti-inflammatory drugs in experimental myocardial infarction in rats. Eur J Pharmacol 69 (1981) 235-238
38. Nichols B.A., and Bainton D.F. Differentiation of human monocytes in bone marrow and blood. Sequential formation of two granule populations. Lab Invest 29 (1973) 27-40
39. Sommers H.M., and Jennings R.B. Experimental acute myocardial infarction; histologic and histochemical studies of early myocardial infarcts induced by temporary or permanent occlusion of a coronary artery. Lab Invest 13 (1964) 1491-1503
40. Crawford M.H., Grover F.L., Kolb W.P., Mcmahan C.A., O'rourke R.A., Mcmanus L.M., et al. Complement and neutrophil activation in the pathogenesis of ischemic myocardial injury. Circulation 78 (1988) 1449-1458
41. De Greef K.E., Ysebaert D.K., Ghielli M., Vercauteren S., Nouwen E.J., Eyskens E.J., et al. Neutrophils and acute ischemia-reperfusion injury. J Nephrol 11 (1998) 110-122
42. Ivey C.L., Williams F.M., Collins P.D., Jose P.J., and Williams T.J. Neutrophil chemoattractants generated in two phases during reperfusion of ischemic myocardium in the rabbit. Evidence for a role for C5a and interleukin-8. J Clin Invest 95 (1995) 2720-2728
43. Kukielka G.L., Hawkins H.K., Michael L., Manning A.M., Youker K., Lane C., et al. Regulation of intercellular adhesion molecule-(ICAM-1) in ischemic and reperfused canine myocardium. J Clin Invest 92 (1993) 1504-1516
44. Irwin M.W., Mak S., Mann D.L., Qu R., Penninger J.M., Yan A., et al. Tissue expression and immunolocalization of tumor necrosis factor-alpha in postinfarction dysfunctional myocardium. Circulation 99 (1999) 1425-1432
45. Corr P.B., Witkowski F.X., and Sobel B.E. Mechanisms contributing to malignant dysrhythmias induced by ischemia in the cat. J Clin Invest 61 (1978) 109-119
46. Baxter G.F. The neutrophil as a mediator of myocardial ischemia-reperfusion injury: time to move on. Basic Res Cardiol 97 (2002) 268-275
47. Rossen R.D., Michael L.H., Hawkins H.K., Youker K., Dreyer W.J., Baughn R.E., et al. Cardiolipin-protein complexes and initiation of complement activation after coronary artery occlusion. Circ Res 75 (1994) 133-141
48. Yasojima K., Kilgore K.S., Washington R.A., Lucchesi B.R., and Mcgeer P.L. Complement gene expression by rabbit heart: upregulation by ischemia and reperfusion. Circ Res 82 (1998) 1224-1230
49. Frangogiannis N.G., Lindsey M.L., Michael L.H., Youker K.A., Bressler R.B., Mendoza L.H., et al. Resident cardiac mast cells degranulate and release preformed TNF-alpha, initiating the cytokine cascade in experimental canine myocardial ischemia/reperfusion. Circulation 98 (1998) 287-295
50. Annable C.R., Mcmanus L.M., Carey K.D., and Pinckard R.N. Isolation of platelet activating factor (PAF) from ischaemic baboon myocardium. Fed Proc 44 (1985) 1271
51. Kukielka G.L., Smith C.W., Larosa G.J., Manning A.M., Mendoza L.H., Daly T.J., et al. Interleukin-8 gene induction in the myocardium after ischemia and reperfusion in vivo. J Clin Invest 95 (1995) 89-103